Crescenta is currently managed by its founders, key scientific advisers, and the director of Akoyat, A.S., its primary investment firm.
Emre Koyuncu, Ph.D. - Founder, Chief Executive Officer
Dr. Koyuncu is an experienced virologist and a serial entrepreneur. He was a founding employee of Forge Life Science, a successfully growing biotech startup. Prior to Forge Life Science, he worked at Princeton University where he generated several novel technologies. His Princeton IP formed a basis for two startup companies and has been licensed/optioned by Kadmon and Merck. Ph.D., University of Hamburg; Post-doc, Princeton University.
Hahn Kim, Ph.D. - Founder, Adviser
Dr. Kim has deep expertise in the area of organic chemistry. He is currently the founding director of the Princeton University Screening Center. He is also a co-founder of Chiromics, where his role was instrumental in Chiromics’ successful research collaborations with companies such as Pfizer, Merck, GSK and Genentech. Ph.D. and post-doc, Princeton University.
Patrick Lam, Ph.D. - Adviser
Dr. Lam has over 27 years of research experience in the field of medicinal chemistry. He was formerly a director in the Discovery Chemistry Department at Bristol-Myers Squibb (BMS). He is the co-inventor of a total of eight clinical candidates and the blockbuster anticoagulant drug Eliquis®/Apixaban.
Lynn Enquist, Ph.D. - Adviser
Dr. Enquist is Henry L. Hillman Professor in Molecular Biology and Professor in the Princeton Neuroscience Institute at Princeton University. His research pioneered the field of study of herpesvirus invasion of the mammalian nervous system. He is a Fellow of the American Academy of Microbiology and the American Association for the Advancement of Sciences (AAAS), and is the president of the American Society for Microbiology.